Literature DB >> 16550161

Mouse models of XRCC1 DNA repair polymorphisms and cancer.

W C Ladiges1.   

Abstract

DNA damage plays a major role in mutagenesis, carcinogenesis and aging. A gene that is emerging as an essential element in the repair of both damaged bases and single-strand breaks (SSB) is XRCC1. XRCC1 has been shown to have a large number of single-nucleotide polymorphisms (SNPs), several of which are being increasingly studied in cancer epidemiology investigations, in part because of their relative high frequency in the population. Although association trends with specific cancer types have occasionally been shown in a variety of ethnic backgrounds, there are often conflicting reports that weaken any substantial conclusions. The functional significance of these SNPs is still largely unknown. XRCC1 is an excellent prototype to provide a forum for determining how epidemiological cancer association studies with DNA repair gene polymorphisms can be validated or refuted. The focus is on the utilization of in silico data and biochemical studies in cell lines and existing mouse models to help provide a framework for the development of new mutant mouse lines that mimic human polymorphisms. These mouse lines will provide the next generation of mammalian tools for carcinogen exposure studies relevant to human cancer and variations in XRCC1, and provide the basis for investigating groups of genes and polymorphisms in an animal model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550161     DOI: 10.1038/sj.onc.1209370

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

Review 1.  Haploinsufficiency in mouse models of DNA repair deficiency: modifiers of penetrance.

Authors:  Diane C Cabelof
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

2.  Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.

Authors:  Rui Gao; Douglas K Price; Tristan Sissung; Eddie Reed; William D Figg
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

Review 3.  Base excision repair capacity in informing healthspan.

Authors:  Boris M Brenerman; Jennifer L Illuzzi; David M Wilson
Journal:  Carcinogenesis       Date:  2014-10-29       Impact factor: 4.944

Review 4.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

5.  Partial loss of the DNA repair scaffolding protein, Xrcc1, results in increased brain damage and reduced recovery from ischemic stroke in mice.

Authors:  Somnath Ghosh; Chandrika Canugovi; Jeong Seon Yoon; David M Wilson; Deborah L Croteau; Mark P Mattson; Vilhelm A Bohr
Journal:  Neurobiol Aging       Date:  2015-04-17       Impact factor: 4.673

Review 6.  Coordination of DNA single strand break repair.

Authors:  Rachel Abbotts; David M Wilson
Journal:  Free Radic Biol Med       Date:  2016-11-24       Impact factor: 7.376

7.  Tumor growth is suppressed in mice expressing a truncated XRCC1 protein.

Authors:  Christina Pettan-Brewer; John Morton; Sarah Cullen; Linda Enns; Keffy Rm Kehrli; Julia Sidorova; Jorming Goh; Rebecca Coil; Warren C Ladiges
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

8.  E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair.

Authors:  Dexi Chen; Zhiyong Yu; Zhiyi Zhu; Charles D Lopez
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

9.  The association between four SNPs of X-ray repair cross complementing protein 1 and the sensitivity to radiotherapy in patients with esophageal squamous cell carcinoma.

Authors:  Yaohong Zhang; Zhaoyun Luo; Liye Yang; Senming Chen; Chuzhi Chen; Zhixiong Lin
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

10.  XRCC1 Polymorphisms and Pancreatic Cancer: A Meta-Analysis.

Authors:  Wei-Dong Shen; Hong-Lin Chen; Peng-Fei Liu
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.